United therapeutics corporation (UTHR)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Cash flows from operating activities:
Net income (loss)

-104,500

589,200

417,900

713,700

651,600

340,100

174,560

304,442

217,868

105,916

19,462

-49,327

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization

45,900

35,900

31,000

31,600

32,900

32,200

31,259

27,145

20,535

17,920

11,394

4,536

Share-based compensation expense

45,400

-26,400

73,500

12,100

280,300

190,100

320,786

30,115

-15,715

113,942

101,015

28,703

Impairments of investments in privately-held companies

-

53,500

49,600

-

-

-

-

-

-

-

-

-

Equity loss in affiliate and other

-

-

-

-

-

-

-

-

-

-

-

2,514

Excess tax benefits from share-based compensation

-

-

-

5,900

37,400

30,800

9,299

3,054

11,347

23,826

4,406

21,090

Impairment charges

17,200

-

-

-

-

-

-

6,804

-

7,688

4,494

-

Gain on sale of intangible asset

-

-

-

-

350,000

-

-

-

-

-

-

-

Other

29,700

-1,800

19,400

-9,500

-7,500

-24,200

-3,182

-14,471

-2,614

-967

1,848

-

Impairment write downs

17,200

-

-

-

-

-

-

-

-

-

-

-

Provision for inventory obsolescence

-

-

-

-

-

-

-

-

5,180

2,398

4,675

586

Expense associated with outstanding license fees

-

-

-

-

-

-

-

-

37,049

-

-

-

Current and deferred income tax expense

-

-

-

-

-

-

-

136,229

81,432

41,923

-1,038

-34,394

Gains/losses on trading securities

-

-

-

-

-

-

-

-

-

-

-

-1,595

Amortization of debt discount and debt issue costs

-

-

-

-

-

-

12,601

11,064

19,359

16,839

15,714

14,670

Amortization of discount or premium on investments

-

-

-

-

-

-

-4,501

-4,604

-4,474

-2,574

-1,551

999

Changes in operating assets and liabilities:
Accounts receivable

-24,400

-121,400

82,700

21,700

30,500

35,700

10,027

23,991

16,158

23,452

21,956

2,329

Inventories

-12,900

-9,300

500

24,500

6,800

21,000

12,394

5,933

16,055

9,196

9,061

2,630

Accounts payable and accrued expenses

-16,300

-11,000

66,200

600

17,000

-6,800

7,507

-22,804

20,251

-

-

-

Other assets and liabilities

201,900

-4,700

61,400

71,800

181,800

137,000

97,409

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

587

-3,422

5,682

Other assets

-

-

-

-

-

-

-

9,705

5,733

4,776

196

16,123

Accounts payable

-

-

-

-

-

-

-

-

-

-2,734

-3,645

18,509

Accrued expenses

-

-

-

-

-

-

-

-

-

25,612

9,203

3,641

Other liabilities

-

-

-

-

-

-

-

-145,759

-93,559

-59,676

-29,057

22,419

Net cash provided by (used in) operating activities

-206,600

778,400

474,200

643,600

382,800

355,300

425,267

323,628

250,195

211,532

99,723

-40,429

Cash flows from investing activities:
Purchases of property, plant and equipment

83,700

184,400

86,300

38,000

49,800

47,400

31,910

111,905

35,978

18,640

95,400

124,415

Proceeds from sale of property, plant and equipment

-

-

8,300

-

-

-

-

-

-

-

-

-

Deposits

-

46,000

-

-

-

-

-

-

-

-

-

-

Purchases of held-to-maturity and other investments

-

99,300

51,800

800

62,800

118,700

762,198

579,316

815,684

662,225

310,634

321,363

Sales/maturities of held-to-maturity investments

39,700

88,600

52,900

130,400

320,400

549,600

529,900

527,858

733,876

421,528

249,083

266,051

Purchases of available-for-sale investments

1,271,500

762,700

718,400

-

-

45,000

30,766

-

-

-

-

24,600

Sales/maturities of available-for-sale investments

980,100

312,300

20,000

-

-

-

-

-

-

-

-

-

Gain on sale of intangible asset

-

-

-

-

350,000

-

-

-

-

-

-

-

Sales of trading investments

-

-

-

-

-

-

-

-

-

36,200

-

31,850

Sales of investments in equity securities

20,500

-

-

-

-

-

-

-

-

-

-

-

Purchase of investments in privately-held companies

8,000

5,000

60,400

36,000

54,200

-

-

-

-

-

-

-

Decrease in cash due to deconsolidation of variable interest entity

12,500

-

-

-

-

-

-

-

-

-

-

-

Purchase of investments under the equity method

-

-

-

2,100

-

-

-

-

-

-

-

-

Consolidation of variable interest entity

-

-

-100

-

-

-

-

-

-

-

-

-

Acquisition, net of cash acquired

-

124,100

-

5,200

-

-

-

-

-

-

-

-

Acquisitions

-

-

-

-

-

-

-

-

3,547

-

3,568

-

Restrictions on cash

-

-

-

-

-

-

-

-

-

-13,901

2,099

8,766

Net cash used in investing activities

-335,400

-820,600

-835,600

48,300

503,600

338,500

-294,974

-163,363

-121,333

-209,236

-162,618

-181,243

Cash flows from financing activities:
Proceeds from line of credit

800,000

250,000

250,000

-

-

140,000

-

-

-

-

-

-

Repayment of line of credit

200,000

250,000

-

-

-

-

-

-

-

-

-

-

Principal payments of debt

-

-

-

8,800

133,200

177,800

1,320

999

251,039

-

-

-

Payments of debt issuance costs

700

13,200

700

6,800

-

-

-

-

-

-

-

-

Payment of lease obligation

-

-

-

-

-

-

-

-

-

31,442

-

-

Payments to repurchase common stock

-

-

250,000

500,000

394,500

483,100

42,439

188,000

212,000

-

-

-

Proceeds from the sale of treasury stock

-

-

-

-

-

-

-

-

-

-

-

150,000

Proceeds from the exercise of stock options

9,900

15,600

39,900

7,700

39,300

50,200

26,611

16,805

24,398

85,427

32,071

41,936

Proceeds from the issuance of stock under employee stock purchase plan

4,100

3,900

4,100

4,300

4,000

3,300

2,734

-

-

-

-

-

Restricted stock units withheld for taxes

2,100

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from share-based compensation

-

-

-

5,900

37,400

30,800

9,299

3,054

11,347

23,826

4,406

21,090

Payments on line of credit

-

-

-

-

-

-140,000

-

-

-

-

-

-

Proceeds received from issuance of debt

-

-

-

-

-

-

-

-

250,000

70,000

-

-

Payments of transaction costs related to issuance of debt

-

-

-

-

-

-

-

-

7,535

1,055

-

-

Payment for convertible note hedge and warrants, net

-

-

-

-

-

-

-

-

33,250

-

-

-

Net cash (used in) provided by financing activities

611,200

6,300

43,300

-497,700

-447,000

-576,600

-5,115

-169,140

-218,079

146,756

36,477

213,026

Effect of exchange rate changes on cash and cash equivalents

-

-

200

-3,000

-5,300

-3,800

-319

229

-269

2,758

-2,682

-1,225

Net increase in cash and cash equivalents

69,200

-35,900

-317,900

191,200

434,100

113,400

124,859

-8,646

-89,486

151,810

-29,100

-9,871

Supplemental cash flow information:
Cash paid for interest

41,000

9,400

7,500

1,500

1,000

5,500

5,518

5,302

4,103

1,818

1,250

1,250

Cash (received) paid for income taxes

120,200

102,700

346,900

362,400

293,300

195,600

142,140

101,505

46,510

22,683

23,931

1,628

Cash paid for settlement of loss contingency

-

-

210,000

-

-

-

-

-

-

-

-

-

Non-cash investing and financing activities:
Acquisitions-non-cash consideration

-

-

-

-

-

5,200

-

-

5,873

-

4,776

-

Lease obligation incurred

-

-

-

-

-

-

-

-

-

-

-

29,000

Non-cash additions to property, plant and equipment

54,500

11,500

11,500

2,900

1,100

3,200

9,018

1,820

23,063

2,445

2,571

6,391

Issuance of common stock upon conversion of convertible notes

-

-

-

7,500

321,800

189,300

-

-

27,294

-

-

-

Assumption of mortgage in connection with the acquisition of property

-

-

-

-

-

-

-

-

3,736

-

-

-